Showing results (131-140 of 537) with videos related to

Sort By:
Pageof 54
Clinics in Dermatology|May 26, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersDavid Dodick, Andrew Blumenfeld, Stephen D Silberstein
Current Opinion in Neurology|March 19, 2019
The endocannabinoid system in migraine: from bench to pharmacy and backCristina Tassorelli, Rosaria Greco, Stephen D Silberstein
Expert Opinion on Pharmacotherapy|March 22, 2023
Current and emerging pharmacotherapy for menstrual migraine: a narrative reviewClaire E J Ceriani, Stephen D Silberstein
Headache|August 9, 2002
Hemicrania continua responds to cyclooxygenase-2 inhibitorsMario F P Peres, Stephen D Silberstein
Headache|September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package sizeStephen D Silberstein, David Dodick, Jim Kesslick
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 27, 2022
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and RationaleFred Cohen, Hsiangkuo Yuan, Stephen D Silberstein
Pharmacology & Therapeutics|June 16, 2010
Cardiovascular risk factors regulate the expression of vascular endothelin receptorsCang-Bao Xu, Yang Sun, Lars Edvinsson
Pageof 54